Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
Public ClinicalTrials.gov record NCT00754013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of donepezil hydrochloride (Aricept) in the treatment of cognitive dysfunction shown by children with Down syndrome, aged 6 to 10 years.
Study identification
- NCT ID
- NCT00754013
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 9 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 10 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Sep 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Jan 27, 2020
2008
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Road Runner Research | San Antonio | Texas | 78258 | — |
| NeuroScience, Inc. | Herndon | Virginia | 20170 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Down Syndrome trials
Other public records listing Down Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792382: Executive Function Play Opportunities for Children With Down Syndrome Not yet recruiting
- NCT06219863: Harness-based Mobility Intervention for Infants With Down Syndrome Recruiting
- NCT06951516: How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome Recruiting
- NCT07625579: Collaboration for Down Syndrome Progress (CDP) Recruiting
- NCT07598643: Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1 Recruiting
- NCT07416201: Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00754013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2020 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00754013 live on ClinicalTrials.gov.